Get the Stockscreener App
0.9385
1.08%
0.0137
Femasys Inc stock is traded at $0.9385, with a volume of 99,576.
It is up +1.08% in the last 24 hours and up +5.12% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.9248
Open:
$0.925
24h Volume:
99,576
Relative Volume:
0.35
Market Cap:
$30.25M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-1.1307
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
+0.59%
1M Performance:
+5.12%
6M Performance:
-10.97%
1Y Performance:
-18.00%
1-Day Range:
$0.91
$0.9398
1-Week Range:
$0.90
$0.9895
52-Week Range:
$0.693
$1.80
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.93 | 30.23M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
518.08 | 191.65B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
173.78 | 49.57B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.33 | 42.93B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
254.26 | 37.60B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
225.27 | 15.91B | 2.90B | 467.20M | 306.90M | 6.37 |
Femasys Inc Stock (FEMY) Latest News
Femasys Secures $10 Million Financing with Alumni Capital Purchase Agreement - AInvest
XENE CEO Named Interim CFO After Sherry Aulin Resigns | FEMY SEC FilingForm 8-K - Stock Titan
Major Breakthrough: Australia and NZ Approve Femasys Revolutionary First-Line Infertility Solutions - Stock Titan
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - The Manila Times
Femasys Achieves Australian and New Zealand Regulatory - GlobeNewswire
Femasys Enters Purchase Agreement with Alumni Capital - TipRanks
Femasys stock rises as FemBloc gets CE Mark for permanent birth control - Investing.com Canada
Femasys Receives European Approval for FemBloc Non-Surgical Permanent Birth Control - Femtech Insider
Femasys appoints Kelley Nicholas as chief commercial officer - Investing.com
Femasys appoints Kelley Nicholas as chief commercial officer By Investing.com - Investing.com Canada
Femasys Appoints Kelley Nicholas as Chief Commercial Officer - TipRanks
Femasys (FEMY) Appoints Kelley Nicholas as Chief Commercial Officer | FEMY Stock News - GuruFocus
Femasys appoints Nicholas as CCO - TipRanks
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewswire
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates - MSN
40,968 Shares in Femasys Inc. (NASDAQ:FEMY) Acquired by Citadel Advisors LLC - Defense World
Femasys (NASDAQ:FEMY) Receives “Buy” Rating from HC Wainwright - Defense World
A Closer Look at Femasys Inc (FEMY) Stock Gains - investchronicle.com
The Analyst Verdict: Femasys In The Eyes Of 6 Experts - Benzinga
Femasys (FEMY): Buy Rating Reiterated by HC Wainwright & Co. | FEMY Stock News - GuruFocus
Femasys: Strategic Partnerships and Revenue Growth Drive Buy Rating with $12 Price Target - TipRanks
Femasys Announces Partnership with Carolinas Fertility - GlobeNewswire
Femasys announces partnership with Carolinas Fertility Institute - TipRanks
Femasys (FEMY) Partners with Carolinas Fertility Institute for FemaSeed Distribution | FEMY Stock News - GuruFocus
Major Fertility Breakthrough: Leading US Clinic Network Adopts Femasys FemaSeed as IVF Alternative - Stock Titan
Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations - The Manila Times
Jane Street Group LLC Acquires New Stake in Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Northern Trust Corp Purchases 37,675 Shares of Femasys Inc. (NASDAQ:FEMY) - Defense World
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up - Asianet Newsable
Femasys Announces Public Offering and Private Placement - TipRanks
Femasys announces pricing of underwritten public offering and concurrent private placement with gross proceeds of $4.5M - MSN
Femasys sets pricing for stock offering and private placement By Investing.com - Investing.com South Africa
Femasys stock hits 52-week low at $0.82 amid market challenges By Investing.com - Investing.com South Africa
FEMY Announces Public Offering and Private Placement Pricing | F - GuruFocus
Femasys stock hits 52-week low at $0.82 amid market challenges - Investing.com Canada
Femasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of Shares - Nasdaq
Femasys prices 3.6M shares at 85c in underwritten public offering - TipRanks
Femasys (FEMY) Announces Stock Offering to Raise $4.5 Million - GuruFocus
Femasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load Up By Stocktwits - Investing.com India
FEMY Announces Public Offering and Private Placement Pricing | FEMY Stock News - GuruFocus
Femasys sets pricing for stock offering and private placement - Investing.com
Femasys Announces Pricing Of Underwritten Public Offering And Concurrent Private Placement With Gross Proceeds Of $4.5 Million - marketscreener.com
Femasys Announces Pricing of Underwritten Public Offering - GlobeNewswire
Women's Health Innovator Femasys Secures $4.5M Strategic Financing to Accelerate Commercial Growth - Stock Titan
Femasys plans stock offering and private placement By Investing.com - Investing.com South Africa
Femasys announces common stock offering, no amount given - TipRanks
Femasys Plans Public Offering, Concurrent Private Placement - MarketScreener
Femasys plans stock offering and private placement - Investing.com
FEMY Announces Public Offering to Fuel Expansion and Development | FEMY Stock News - GuruFocus
Shootin' the Bull about growing everything bigger - The Globe and Mail
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):